Literature DB >> 2447144

Release of tryptase together with histamine during the immediate cutaneous response to allergen.

L B Schwartz1, P C Atkins, T R Bradford, P Fleekop, M Shalit, B Zweiman.   

Abstract

Better in vivo techniques are needed for objective assessment of mast cell-dependent events. Tryptase, a neutral protease selectively concentrated in human mast cells, appears along with histamine in skin chamber fluid overlying sites of allergen challenge in sensitive human subjects. Maximal amounts of histamine were found 0 minutes to 30 minutes after challenge; maximal amounts of tryptase were found 30 minutes to 60 minutes after challenge. The later appearance of tryptase most likely reflects its slower diffusion through tissue after release of tryptase from cutaneous mast cells as a macromolecular complex with proteoglycan. The mean weight ratio of tryptase (134,000 molecular weight tetramer) to histamine (111 molecular weight) in chamber fluid after allergen challenge during a 1-hour time course was 4:1. Total amounts of tryptase and histamine recovered in the 0.3 ml chamber fluid samples after a 1-hour challenge averaged 95 ng and 26 ng, respectively. Tryptase levels in skin chamber fluid are an accurate indicator of mast cell activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447144     DOI: 10.1016/s0091-6749(87)80276-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  14 in total

1.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

Authors:  L B Schwartz; J W Yunginger; J Miller; R Bokhari; D Dull
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 2.  Tryptase as a polyfunctional component of mast cells.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Vera Samoilova; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2018-03-12       Impact factor: 4.304

3.  Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Authors:  L B Schwartz; T R Bradford; C Rouse; A M Irani; G Rasp; J K Van der Zwan; P W Van der Linden
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

4.  Cloning and characterization of complementary DNA for human tryptase.

Authors:  J S Miller; E H Westin; L B Schwartz
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 5.  Mast cell proteases as protective and inflammatory mediators.

Authors:  George H Caughey
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 6.  Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?

Authors:  A Matito; M Carter
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 7.  Mast cell chymase: morphofunctional characteristics.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2019-08-08       Impact factor: 4.304

8.  Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy.

Authors:  J Santos; C Bayarri; E Saperas; C Nogueiras; M Antolín; M Mourelle; A Cadahia; J R Malagelada
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

9.  Evaluation of mast cell activation (tryptase) in two patients suffering from drug-induced hypotensoid reactions.

Authors:  P Matsson; I Enander; A S Andersson; J Nystrand; L Schwartz; J Watkins
Journal:  Agents Actions       Date:  1991-05

10.  Mast Cell Activation and KSHV Infection in Kaposi Sarcoma.

Authors:  Leona W Ayers; Arturo Barbachano-Guerrero; Shane C McAllister; Julie A Ritchie; Elizabeth Asiago-Reddy; Linda C Bartlett; Ethel Cesarman; Dongliang Wang; Rosemary Rochford; Jeffrey N Martin; Christine A King
Journal:  Clin Cancer Res       Date:  2018-07-03       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.